Sunnyvale, CA, United States of America

Steve Oh

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Mountain View, CA (US) (2016)
  • Sunnyvale, CA (US) (2019 - 2021)
  • St. Louis, MO (US) (2020 - 2021)

Company Filing History:


Years Active: 2016-2021

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Steve Oh: Innovator in Nucleic Acid Technologies

Introduction

Steve Oh is a prominent inventor based in Sunnyvale, California. He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid technologies. With a total of six patents to his name, Steve has developed innovative methods that enhance the efficiency of nucleic acid manipulation.

Latest Patents

Among his latest patents, Steve has developed methods for depleting a target nucleic acid in a sample. These methods involve contacting the target nucleic acid with two or more polymers that specifically hybridize to it, followed by cleaving the hybridized regions to effectively deplete the target nucleic acid. Additionally, he has created methods for adding adapters to nucleic acids. This process includes combining a template ribonucleic acid (RNA) with a template switch oligonucleotide and a sequencing platform adapter construct, resulting in a product nucleic acid that incorporates both the template RNA and the oligonucleotide.

Career Highlights

Steve Oh is currently employed at Takara Bio USA, Inc., where he continues to push the boundaries of nucleic acid research. His work has been instrumental in developing practical applications for his inventions, which are crucial for advancements in genetic research and diagnostics.

Collaborations

Steve has collaborated with notable colleagues, including Andrew Alan Farmer and Ian B Oglesby. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.

Conclusion

Steve Oh is a key figure in the field of nucleic acid technologies, with a strong portfolio of patents that reflect his innovative spirit. His contributions are paving the way for future advancements in molecular biology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…